Literature DB >> 8564227

Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.

K Horie1, K Obika, R Foglar, G Tsujimoto.   

Abstract

1. To investigate the structure-activity relationships of alpha-adrenoceptor agonists for the alpha 1-adrenoceptor subtypes, we have compared the imidazoline class of compounds, oxymetazoline and cirazoline, with the phenethylamine, noradrenaline, in their affinities and also in their intrinsic activities in Chinese hamster ovary (CHO) cells stably expressing the cloned human alpha 1-adrenoceptor subtypes (alpha 1a-, alpha 1b-, and alpha 1d-subtypes). 2. Radioligand binding studies with [125I]-HEAT showed that cirazoline and oxymetazoline had higher affinities at alpha 1a-subtype than at alpha 1b- and alpha 1d-subtypes, while noradrenaline had higher affinity at the alpha 1d-subtype than at alpha 1a- and alpha 1b-subtypes. 3. In functional studies, cirazoline caused transients of cytosolic Ca2+ concentrations ([Ca2+]i response) in a concentration-dependent manner and developed a maximal response similar to that to noradrenaline in CHO cells expressing the alpha 1a-subtype, while it acted as a partial agonist at alpha 1b- and alpha 1d-adrenoceptors. Oxymetazoline, on the other hand, was a weak agonist at alpha 1a-adrenoceptors, and has no intrinsic activity at the other subtypes. 4. Using the phenoxybenzamine inactivation method, the relationships between receptor occupancy and noradrenaline-induced [Ca2+]i response for alpha 1a- and alpha 1d-subtypes were found to be linear, whereas it was moderately hyperbolic for the alpha 1b-subtype, indicating the absence of receptor reserves in CHO cells expressing alpha 1a- and alpha 1d-subtypes while there exists a small receptor reserve for CHO cells expressing the alpha 1b-subtype. 5 In summary, our data obtained in cells exclusively expressing a single receptor subtype support the idea that the relative role of agonist affinity and intrinsic activity may vary depending on the subtype of alphal-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564227      PMCID: PMC1908909          DOI: 10.1111/j.1476-5381.1995.tb16381.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Further characterization of the myocardial alpha-adrenoceptors mediating positive inotropic effects in the rabbit myocardium.

Authors:  T Hiramoto; H Kushida; M Endoh
Journal:  Eur J Pharmacol       Date:  1988-08-02       Impact factor: 4.432

2.  Involvement of threshold level in the contractile responses for some alpha 1-andrenoceptor agonists in the rabbit iris dilators.

Authors:  F Konno; I Takayanagi
Journal:  Gen Pharmacol       Date:  1989

3.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Authors:  S Cotecchia; D A Schwinn; R R Randall; R J Lefkowitz; M G Caron; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Alpha-1 adrenergic receptor binding and contraction of rat caudal artery.

Authors:  P W Abel; K P Minneman
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

5.  Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.

Authors:  R R Ruffolo; R L Zeid
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

6.  An evaluation of the ability of a series of full alpha-1 adrenoceptor agonists to release internal calcium in venous smooth muscle.

Authors:  K F Jim; R A Macia; W D Matthews
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

7.  The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells.

Authors:  K Horie; A Hirasawa; G Tsujimoto
Journal:  Eur J Pharmacol       Date:  1994-08-16       Impact factor: 4.432

8.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

9.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

10.  Alpha 1-adrenergic receptor-linked guanine nucleotide-binding protein in muscle and kidney epithelial cells.

Authors:  B I Terman; S R Slivka; R J Hughes; P A Insel
Journal:  Mol Pharmacol       Date:  1987-01       Impact factor: 4.436

View more
  8 in total

1.  Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex.

Authors:  Dibyadeep Datta; Sheng-Tao Yang; Veronica C Galvin; John Solder; Fei Luo; Yury M Morozov; Jon Arellano; Alvaro Duque; Pasko Rakic; Amy F T Arnsten; Min Wang
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

2.  Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction.

Authors:  M Ibarra; J P Pardo; J J Lopez-Guerrero; R Villalobos-Molina
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes.

Authors:  Ramona Petrovska; Ivo Kapa; Janis Klovins; Helgi B Schiöth; Staffan Uhlén
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy.

Authors:  K Shibata; A Hirasawa; N Moriyama; K Kawabe; S Ogawa; G Tsujimoto
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways.

Authors:  Joanna Richardson; Heather Chatwin; Akira Hirasawa; Gozoh Tsujimoto; Peter D Evans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-20       Impact factor: 3.000

6.  alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse.

Authors:  Van A Doze; Evelyn M Handel; Kelly A Jensen; Belle Darsie; Elizabeth J Luger; James R Haselton; Jeffery N Talbot; Boyd R Rorabaugh
Journal:  Brain Res       Date:  2009-06-18       Impact factor: 3.252

7.  Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils.

Authors:  Ingrid Beck-Speier; Barbara Oswald; Konrad L Maier; Erwin Karg; René Ramseger
Journal:  J Pharmacol Sci       Date:  2009-07       Impact factor: 3.337

Review 8.  Ligands of Adrenergic Receptors: A Structural Point of View.

Authors:  Yiran Wu; Liting Zeng; Suwen Zhao
Journal:  Biomolecules       Date:  2021-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.